Literature DB >> 24409337

Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report.

Marcello Maida1, Fabio Salvatore Macaluso1, Massimo Galia1, Giuseppe Cabibbo1.   

Abstract

A 68-year-old Caucasian man with hepatitis C virus-related cirrhosis was admitted to our Unit in February 2010 for a diagnostic evaluation of three centimetric hypoechoic focal liver lesions detected by regular surveillance ultrasound. The subsequent computer tomography (CT) led to a diagnosis of unifocal hepatocellular carcinoma (HCC) in VI hepatic segment, defined the other two nodules in the VI and VII segment as suspected metastases, and showed a luminal narrowing with marked segmental circumferential thickening of the hepatic flexure of the colon. Colonoscopy detected an ulcerated, bleeding and stricturing lesion at the hepatic flexure, which was subsequently defined as adenocarcinoma with a moderate degree of differentiation at histological examination. Finally, ultrasound-guided liver biopsy of the three focal liver lesions confirmed the diagnosis of HCC for the nodule in the VI segment, and characterized the other two lesions as metastases from colorectal cancer. The patient underwent laparotomic right hemicolectomy with removal of thirty-nine regional lymph nodes (three of them tested positive for metastasis at histological examination), and simultaneous laparotomic radio-frequency ablation of both nodule of HCC and metastases. The option of adjuvant chemotherapy was excluded because of the post-surgical onset of ascites. Abdomen CT and positron emission tomography/CT scans performed after 1, 6 and 12 mo highlighted a complete response to treatments without any radiotracer accumulation. After 18 mo, the patient died due to progressive liver failure. Our experience emphasizes the potential coexistence of two different neoplasms in a cirrhotic liver and the complexity in the proper diagnosis and management of the two tumours.

Entities:  

Keywords:  Cirrhosis; Colorectal cancer; Hepatocellular carcinoma; Liver metastases

Year:  2013        PMID: 24409337      PMCID: PMC3879692          DOI: 10.4254/wjh.v5.i12.696

Source DB:  PubMed          Journal:  World J Hepatol


  14 in total

1.  Multiple primary malignant neoplasms: historical perspectives.

Authors:  C G Moertel
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 3.  Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 4.  Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.

Authors:  Morris Sherman
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

5.  A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?

Authors:  Adrian B Cresswell; Fenella K S Welsh; Myrddin Rees
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

Review 6.  Should cirrhosis change our attitude towards treating non-hepatic cancer?

Authors:  Giuseppe Cabibbo; Laura Palmeri; Sergio Palmeri; Antonio Craxì
Journal:  Liver Int       Date:  2011-08-31       Impact factor: 5.828

Review 7.  Assessment of treatment response in hepatocellular carcinoma: a review of the literature.

Authors:  Marcello Maida; Giuseppe Cabibbo; Giuseppe Brancatelli; Chiara Genco; Nicola Alessi; Claudio Genova; Piero Romano; Maurizio Raineri; Antonello Giarratano; Massimo Midiri; Calogero Cammà
Journal:  Future Oncol       Date:  2013-06       Impact factor: 3.404

8.  Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer.

Authors:  Masashi Ueno; Tetsuichiro Muto; Masatoshi Oya; Hirotoshi Ota; Kaoru Azekura; Toshiharu Yamaguchi
Journal:  Int J Clin Oncol       Date:  2003-06       Impact factor: 3.402

9.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

10.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

View more
  3 in total

1.  Hepatocellular carcinoma incidentally detected at second hepatectomy for repeated colorectal liver metastasis in a patient with hepatitis C virus-related cirrhosis: a case report.

Authors:  Atsuo Kobayashi; Daisuke Morioka; Chizuru Matsumoto; Yasuhiko Miura; Masaru Miura
Journal:  J Med Case Rep       Date:  2016-05-27

2.  Synchronous Hepatic Epithelioid Hemangioendothelioma and Hepatocellular Carcinoma: First Case Report in the Literature and Challenges.

Authors:  Panagiotis G Athanasopoulos; Christopher Hadjittofi; Tu Vinh Luong; James O'Beirne; Dinesh Sharma
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

3.  Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.

Authors:  Ye-Wei Liu; Frederik De Keyzer; Yuan-Bo Feng; Feng Chen; Shao-Li Song; Johan Swinnen; Guy Bormans; Raymond Oyen; Gang Huang; Yi-Cheng Ni
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.